M87.19
Osteonecrosis due to drugs, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Osteonecrosis due to drugs, classified under ICD-10 code M87.19, is a condition where bone tissue dies as a result of medication use. This condition can affect multiple sites in the body, leading to joint pain, bone weakness, and potential mobility issues. It is important to recognize the signs, causes, and available management strategies to better understand this serious complication associated with certain medications.
Causes & Symptoms
Clinical Causes: Prolonged use of corticosteroids such as prednisone or dexamethasone. Use of immunosuppressive drugs for conditions like rheumatoid arthritis or after organ transplants. High-dose or long-term use of certain chemotherapeutic agents used in cancer treatment. Medications that impair blood supply to bones, leading to ischemia. Combination therapies that increase risk, especially with drugs affecting bone metabolism.
Key Symptoms: Joint pain, often severe and sudden in some cases. Pain worsening with activity or weight-bearing. Reduced joint mobility or stiffness. Swelling in affected areas. Possible areas affected include hips, knees, shoulders, and other large joints. In advanced stages, there may be bone collapse or deformity. In some cases, no symptoms are evident until significant damage has occurred.
Diagnostic & Treatment
Diagnosis Path: Diagnosing osteonecrosis involves a combination of medical history, physical examination, and imaging tests. Key steps include: - Reviewing medication history for drugs known to cause osteonecrosis. - Physical assessment to evaluate joint function and tenderness. - Imaging techniques such as X-rays, MRI scans, or bone scans to identify areas of bone death and structural changes. - Laboratory tests may be used to rule out other conditions or assess overall bone health. Early detection through imaging is crucial to prevent severe joint damage.
Treatment Protocols: Management of osteonecrosis related to drugs focuses on relieving symptoms, preserving joint function, and preventing progression. Common approaches include: - Rest and activity modification to reduce stress on affected joints. - Pain management with medications such as NSAIDs. - Physical therapy to maintain joint mobility and strengthen surrounding muscles. - Surgical options may include core decompression, bone grafts, or joint replacement in advanced cases. - Addressing the underlying cause, such as adjusting or discontinuing the offending medication under medical supervision. - Use of medications that promote bone health or improve blood flow may be considered, depending on individual cases. Early intervention can significantly improve outcomes and help maintain quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M87.19 a billable ICD-10 code?
Yes, M87.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M87.19?
Clinical documentation must specify the nature of Osteonecrosis due to drugs, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
